BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » mesenchymal stem cells » Page 11

Epic Year for Regenerative Medicine Investments

July 17, 2015 By Cade Hildreth (CEO) Leave a Comment

EPIC YEAR FOR REGENERATIVE MEDICINE INVESTMENTS

In the past twelve months, regenerative medicine investments gained momentum, as new and promising clinical data got released. The momentum has been growing in recent years, enabling the cell therapy and genome editing sectors to evolve into a global industry.

[Read more…]

Filed Under: Adipose SCs, HSCs, iPS Cells, MSCs, Neural Stem Cells, Stem Cells Tagged With: financial events, Juno Therapeutics, mesenchymal stem cells, regenerative medicine, regenerative medicine industry

Mesenchymal Stem Cell Industry News Round Up | July 2015

July 16, 2015 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal Stem Cell Industry News July 2015 Round-Up

The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for July 2015.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: current events, IL-17, industry news, mesenchymal stem cells, Mesoblast Limited, MiMedx, systematic lupus erythematosus

Mesenchymal Stem Cell Industry News Round Up | June 2015

June 22, 2015 By Cade Hildreth (CEO) Leave a Comment

Mesenchymal Stem Cell Current Events

The mesenchymal stem cell industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about mesenchymal stem cell industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant mesenchymal stem cell industry events for June 2015.

[Read more…]

Filed Under: MSCs, Stem Cells Tagged With: adipose-derived stem cells, Ampion, current events, cystic fibrosis, industry news, mesenchymal stem cells, osteoblasts, osteoporosis, Stemedica

Adult and Fetal Isolation Sources for Mesenchymal Stem Cells (MSCs)

June 1, 2015 By Cade Hildreth (CEO) Leave a Comment

Adult and Fetal Isolation Sources for Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells can be derived from a diverse range of tissues. Originally, Friedenstein et al. isolated MSCs from the bone marrow (BM) and stroma of the spleen and thymus.[1][2] MSCs have since been derived from tissues as varied as the brain, spleen, liver, kidney, lung, bone marrow, muscle, thymus, and pancreas.[3]  However, bone marrow aspirates are still considered to be the most convenient and enriched source of MSCs.[4]

Fetal tissue also contains MSCs, with common sources including umbilical cord blood and fetal placenta. These sources may represent ontogenetically younger MSCs. Evidence exists that MSCs from fetal sources can undergo more cell divisions before they reach senescence than MSCs from adult tissue.[5] [Read more…]

Filed Under: MSCs, Stem Cells Tagged With: isolation, market research, mesenchymal stem cells, sources, stem cells

Cord Blood Industry News Round-Up | May 2015

May 28, 2015 By Cade Hildreth (CEO) Leave a Comment

Cord Blood Industry News May 2015

The cord blood banking industry is well-known for its shifting dynamics, including new alliances, new research advances and innovations. Every month there are major new events that affect market participants.

While it may be possible to stay informed about cord blood industry news in your region, it can be more difficult to track changes on a global scale. For that reason, the following is a summary of significant cord blood industry events for May 2015. [Read more…]

Filed Under: Cord Blood, HSCs, MSCs Tagged With: cord blood, Cord Blood America, Cord Blood Registry, Cryo-Cell, current events, hematopoietic stem cells, industry news, mesenchymal stem cells

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.